Feasibility of a Lifestyle Intervention for Women With Triple-negative Breast Cancer Under Neoadjuvant Immunotherapy

Triple-negative breast cancer (TNBC) is considered a tumor with a high risk of recurrence and metastasis and requires aggressive systemic therapy combining immunotherapy and chemotherapy. If the therapy leads to complete remission (pCR), this is prognostically beneficial for patients. Studies demonstrating the influence of the microbiome on the development of cancer and on the efficacy and toxicity of immunotherapy and chemotherapy underscore the potential of targeted nutritional interventions. Current data from microbiome research indicate that a high-fiber, gut-healthy diet modulates the mi

Trial Details

NCT ID
NCT07311083
Phase
NA
Sponsor
Kliniken Essen-Mitte
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • switching to a high-fibre diet
  • official dietary recommendations
Locations (sample)
  • Essen, North Rhine-Westphalia, Germany|51.45657,7.01228

Key Eligibility Criteria

  • Female patients aged 18-75
  • Histologically confirmed diagnosis of non-metastatic triple-negative breast cancer (TNM stage I-III) with planned neoadjuvant chemotherapy and immu…
  • Willingness to participate in the study and signed consent form

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →